SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-094586
Filing Date
2021-07-21
Accepted
2021-07-21 21:31:02
Documents
1
Period of Report
2021-07-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2122765-2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2122765-2_3seq1.xml 3 10277
  Complete submission text file 0001104659-21-094586.txt   13174
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Reporting) CIK: 0001425738 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40646 | Film No.: 211105839

Mailing Address ONE LETTERMAN DRIVE, BUILDING D SUITE D3-300 SAN FRANCISCO CA 94129
Business Address
Green Jeremy (Reporting) CIK: 0001650527 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40646 | Film No.: 211105837

Mailing Address 18105 SE MILL PLAIN BLVD VANCOUVER WA 98683
Business Address 18105 SE MILL PLAIN BLVD VANCOUVER WA 98683 (360) 949-1041
Absci Corp (Issuer) CIK: 0001672688 (see all company filings)

IRS No.: 453931977 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address LETTERMAN DIGITAL ARTS CENTER ONE LETTERMAN DRIVE, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address LETTERMAN DIGITAL ARTS CENTER ONE LETTERMAN DRIVE, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Biopharma Investments II, L.P. (Reporting) CIK: 0001772230 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40646 | Film No.: 211105838